235 related articles for article (PubMed ID: 11243511)
1. Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy.
Comín-Colet J; Sánchez-Corral MA; Alegre-Sancho JJ; Valverde J; López-Gómez D; Sabaté X; Juan-Mas A; Esplugas E
Lupus; 2001; 10(1):59-62. PubMed ID: 11243511
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine in systemic lupus erythematosus (SLE).
Ponticelli C; Moroni G
Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
[TBL] [Abstract][Full Text] [Related]
3. No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine.
Friedman D; Lovig L; Halushka M; Clancy RM; Izmirly PM; Buyon JP
Clin Exp Rheumatol; 2017; 35(5):857-859. PubMed ID: 28598777
[TBL] [Abstract][Full Text] [Related]
4. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.
Nord JE; Shah PK; Rinaldi RZ; Weisman MH
Semin Arthritis Rheum; 2004 Apr; 33(5):336-51. PubMed ID: 15079764
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
[TBL] [Abstract][Full Text] [Related]
8. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.
Costedoat-Chalumeau N; Hulot JS; Amoura Z; Leroux G; Lechat P; Funck-Brentano C; Piette JC
Rheumatology (Oxford); 2007 May; 46(5):808-10. PubMed ID: 17202178
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria.
Esteve-Valverde E; Tapiz-Reula A; Ruiz D; Alijotas-Reig J
Rheumatol Int; 2020 May; 40(5):777-783. PubMed ID: 31865445
[TBL] [Abstract][Full Text] [Related]
11. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
[TBL] [Abstract][Full Text] [Related]
12. The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Miyagawa I; Nakano K; Nakayamada S; Iwata S; Hanami K; Fukuyo S; Kubo S; Kawabe A; Miyazaki Y; Inoue Y; Ueno M; Ohkubo N; Fujita Y; Tanaka Y
Int J Rheum Dis; 2020 Apr; 23(4):549-558. PubMed ID: 32020727
[TBL] [Abstract][Full Text] [Related]
13. Myopathy complicating lupus pregnancy.
Priori R; Gattamelata A; d'Amati G; Giordano C; Piccioni MG; Valesini G; Framarino-dei-Malatesta M
J Clin Rheumatol; 2013 Apr; 19(3):132-3. PubMed ID: 23519179
[TBL] [Abstract][Full Text] [Related]
14. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
Takamasu E; Yokogawa N; Shimada K; Sugii S
Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
[TBL] [Abstract][Full Text] [Related]
15. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
[TBL] [Abstract][Full Text] [Related]
16. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
[TBL] [Abstract][Full Text] [Related]
17. [Dramatic auriculoventricular bloc in a young woman with acute systemic lupus erythematosus. Implantation of a relay pacemaker].
Slama R; Menkes C; Motte G; Braun S; Forette B; Vanetti A
Bull Mem Soc Med Hop Paris; 1968 Feb 9-16; 119(3):283-93. PubMed ID: 5703992
[No Abstract] [Full Text] [Related]
18. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
19. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
[TBL] [Abstract][Full Text] [Related]
20. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
Hu C; Lu L; Wan JP; Wen C
Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]